The big news of the morning at least was the MNKD data and all we need now is GTXI to complete the trifecta. The markets were a little better in.
Very little news of interest today. The markets continue to be a low volume chop fest with biotechs tending to bear the brunt of the selling. I think a lot.
Well this was a fittingly slow day to a slow weak with much more of the same in terms of trading and performance of biotechs. They seemed to have a.
We have a combination of low volume and negative near term sentiment and thus biotechs have been weak. Most of the selling looks to be on low volume, so it.
It was actually a quiet start to the week but there are a couple of points that I want to make and issues to put on the radar. 1. I.
Lots of good earnings and conference calls to go through. It is going to take a couple of days to sort through it all so I will try and focus.
While today seemed to have better trading action, the news was actually less interesting than Monday. There are a couple of notes but nothing quite significant. In fact, the most.
It was a relatively quiet day on the news front outside of the hep-C space where there as some news on both VRTX and GILD. Not much happening in the.
The news du jour today was SRPT and I want to focus today’s note entirely on it because there is a lot to talk about. In addition, I want to.
It is more of the same in that the market is a little quiet on news. I expected that there would be something interesting to talk about today but not.